Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

US Patent 11299497 · Granted Apr 12, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2024
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2024
Small molecule modulators of IL-172022
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesteras2022
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021